| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 08/15/2002 | US20020110858 Lymphocytic membrane proteins |
| 08/15/2002 | US20020110853 Polypeptide; for use in the treatment of tumors |
| 08/15/2002 | US20020110840 Detecting modulators of interferon generation; obtain cells, incubate with modulator, monitor concentration of inflammatory cytokine, amplified cytokine concentration indicates modulators |
| 08/15/2002 | US20020110804 Secreted factors |
| 08/15/2002 | US20020110608 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 08/15/2002 | US20020110560 Lowering elevated post-prandial blood glucose levels in mammals by increasing incretin half-life comprising administering inhibitor of Dipeptidyl Peptidase (DP IV) or enzymes having DP-IV-like activity |
| 08/15/2002 | US20020110552 Stabilized liquid preparation of the protease which activates blood coagulation factor VII, or of its proenzyme |
| 08/15/2002 | US20020110551 Administering to the individual therapeutically effective amount of human acid alpha-glucosidase at regular interval for therapy of glycogen storage disease type II |
| 08/15/2002 | CA2441948A1 Glycine betaine and its use as anti-hemorrhagic agent |
| 08/15/2002 | CA2437717A1 G-protein coupled receptors |
| 08/15/2002 | CA2437573A1 Methods for diagnosing and treating heart disease |
| 08/15/2002 | CA2437571A1 Receptors and membrane-associated proteins |
| 08/15/2002 | CA2437570A1 Methods for diagnosing and treating heart disease |
| 08/15/2002 | CA2437497A1 Lipid-associated molecules |
| 08/15/2002 | CA2437437A1 Triazoloquinazoline and pyrazolotriazolopyrimidine derivatives, pharmaceutical, composition adenosine a3 receptor affinitive agent, intraocular-pressure reducing agent, pharmaceutical preparation for prevention and treatment of glaucoma, and intraocular-pressure reducing method |
| 08/15/2002 | CA2437434A1 Method for identifying compounds modulating reverse cholesterol transport |
| 08/15/2002 | CA2437405A1 Potassium channel openers |
| 08/15/2002 | CA2437400A1 Aminal diones as potassium channel openers |
| 08/15/2002 | CA2437260A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 08/15/2002 | CA2437248A1 Jnk inhibitor |
| 08/15/2002 | CA2437215A1 Dihydropyrazolopyridine compounds and pharmaceutical use thereof |
| 08/15/2002 | CA2437085A1 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidines and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists |
| 08/15/2002 | CA2436837A1 Carboxylic acid amides, the preparation thereof and their use as pharmaceutical compositions |
| 08/15/2002 | CA2436741A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents |
| 08/15/2002 | CA2436738A1 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose |
| 08/15/2002 | CA2436735A1 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof |
| 08/15/2002 | CA2436465A1 Prediction of wound healing by urinary nitrate assay |
| 08/15/2002 | CA2435844A1 Method and composition for rejuvinating cells, tissues, organs, hair and nails |
| 08/15/2002 | CA2435820A1 Phenoxy substituted benzocondensed heteroaryl derivatives as thyroid receptor ligands |
| 08/15/2002 | CA2435620A1 Enteric nervous system derived stem and progenitor cells and uses thereof |
| 08/15/2002 | CA2435492A1 Antithrombotic compounds, the preparation thereof and their use as pharmaceutical compositions |
| 08/15/2002 | CA2434944A1 Secreted proteins |
| 08/15/2002 | CA2432188A1 Thiazole derivatives for treating ppar related disorders |
| 08/14/2002 | EP1231279A1 Process for producing tripeptides |
| 08/14/2002 | EP1231212A1 Pharmaceutical compositions for the treatment of disorders of the CNS and other disorders |
| 08/14/2002 | EP1231211A1 Thiazolidinedione derivatives as antidiabetic agents |
| 08/14/2002 | EP1231208A2 4-oxocyclic ureas useful as antiarrhythmic and antifibrillatory agents |
| 08/14/2002 | EP1230929A1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring |
| 08/14/2002 | EP1230923A1 Tocotrienols as inhibitors for neovascularisation, cell multiplication, lumen formation and fgf |
| 08/14/2002 | EP1230367A1 19 human secreted proteins |
| 08/14/2002 | EP1230360A2 15 human secreted proteins |
| 08/14/2002 | EP1230349A2 Nucleic acids encoding endotheliases, endotheliases and uses thereof |
| 08/14/2002 | EP1230342A1 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues |
| 08/14/2002 | EP1230259A1 S-allylmercaptoglutathione and uses thereof |
| 08/14/2002 | EP1230255A1 25 human secreted proteins |
| 08/14/2002 | EP1230252A1 Beta-d-5-thioxylose derivatives, preparation method and therapeutic use |
| 08/14/2002 | EP1230243A1 Poycyloalkylpurines as adenosine receptor antagonists |
| 08/14/2002 | EP1230241A2 Adenosine receptor antagonists and methods of making and using the same |
| 08/14/2002 | EP1230236A1 Compound with growth hormone releasing properties |
| 08/14/2002 | EP1230227A1 Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors |
| 08/14/2002 | EP1230222A1 1-benzylpyrazoles-3-carboxylic acid tricyclic derivatives as cannabinoid receptor antagonists |
| 08/14/2002 | EP1230215A1 Pyrrole derivatives as phosphodiesterase vii inhibitors |
| 08/14/2002 | EP1229965A2 Placental human neurokinin b precursor |
| 08/14/2002 | EP1229954A1 Method of treating cardio pulmonary diseases with no group compounds |
| 08/14/2002 | EP1229941A2 Nucleic acid-containing complex |
| 08/14/2002 | EP1229921A1 Heparanase inhibitors for the treatment of heart failure |
| 08/14/2002 | EP1229910A1 Integrin receptor antagonists |
| 08/14/2002 | EP1229907A1 Prevention of plaque rupture by acat inhibitors |
| 08/14/2002 | EP1189922A4 Steroid derivatives |
| 08/14/2002 | EP1071455A4 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 08/14/2002 | EP0988038B1 (imidazol-5-yl)methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation |
| 08/14/2002 | EP0814823B1 Polyphenol fractions of tea, the use thereof and formulations containing them |
| 08/14/2002 | EP0807111B1 Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing same |
| 08/14/2002 | EP0724435B1 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 08/14/2002 | DE10105989A1 Substituierte Oxazolidinone und ihre Verwendung Substituted oxazolidinones and their use |
| 08/14/2002 | DE10105040A1 Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems Tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 08/14/2002 | DE10105038A1 Tripeptide und Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system |
| 08/14/2002 | CN1364170A Thiophene A2A receptor agaonists |
| 08/14/2002 | CN1364168A Hydrochloride of fused-heterocycle compound |
| 08/14/2002 | CN1364166A Polymorphic salt as medicine for migraine |
| 08/14/2002 | CN1364155A N-Cyanomethyl amides as protease inhibitors |
| 08/14/2002 | CN1364087A Methods of treatment and drug screening methods |
| 08/14/2002 | CN1364085A Use of phyllanthus for treating chronically inflammatory and fibrotic processes |
| 08/14/2002 | CN1363359A Jinma capsule for building up body and relieving pain |
| 08/14/2002 | CN1363346A Nano medicine 'Naoan' and its preparing process |
| 08/14/2002 | CN1363344A Nano medicine 'Buxinqi' and its preparing process |
| 08/14/2002 | CN1363342A Nano medicine 'Mailuoning' and its preparing process |
| 08/14/2002 | CN1363339A Nano medicine 'Compound Kendir' and its preparing process |
| 08/14/2002 | CN1363336A Nano encommia bark medicine and its preparing process |
| 08/14/2002 | CN1363331A Nano storax medicine and its preparing process |
| 08/14/2002 | CN1363329A Nano sophora fruit medicine and its preparing process |
| 08/14/2002 | CN1363328A Nano medicine 'Guanmaining' and its preparing process |
| 08/14/2002 | CN1363320A Nano medicine 'Yanghe' and its preparing process |
| 08/14/2002 | CN1363318A Capsule 'Jingmaitong' |
| 08/14/2002 | CN1363316A Medicine for treating venous thrombus and its preparing process |
| 08/14/2002 | CN1363302A Nano medicine 'Fangfeng Tongsheng' and its preparing process |
| 08/14/2002 | CN1363299A Nano medicine 'Shenfu' and its preparing process |
| 08/14/2002 | CN1363296A Nano medicine 'Zixinyin' and its preparing process |
| 08/14/2002 | CN1363294A Nano medicine 'Xinxuening' and its preparing process |
| 08/14/2002 | CN1363288A Nano medicine for eliminating thrombus and its preparing process |
| 08/14/2002 | CN1363286A Nano musk medicine for protecting heart and its preparing process |
| 08/14/2002 | CN1363273A Medicine for treating vascular endotheliocyte disfunction type cardiovascular disease |
| 08/14/2002 | CN1088998C In travenous injection medicine for curing ischemic cerebrovascular disease and its preparing method |
| 08/14/2002 | CN1088997C Chinese-medical oral liquid for treating cerebral diseases caused by hypertension and its preparing process |
| 08/14/2002 | CA2371487A1 Tricyclic sulfonamide matrix metalloproteinase inhibitors |
| 08/14/2002 | CA2371481A1 Sulfonamide matrix metalloproteinase inhibitors |
| 08/14/2002 | CA2371480A1 Biphenyl sulfonamides useful as matrix metalloproteinase inhibitors |
| 08/13/2002 | US6433202 Antiinflammatory agents |
| 08/13/2002 | US6433197 Reacting arylhydroxy compound and an epoxy compound to form an epoxy-aryl ether; reacting epoxy-aryl ether with active methylene compound to form a lactone; reducing to provide hydroxy-substituted tetrahydrofuran |
| 08/13/2002 | US6433182 Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |